Biocon is India's largest biopharmaceutical company, founded in 1978 by Kiran Mazumdar-Shaw. It specializes in insulin production and biosimilars. Biocon was the first Indian company to receive FDA approval for a biosimilar. The company contributes significantly to India's biotechnology sector, with a focus on affordable healthcare. Biocon also engages in extensive research and development, enhancing India's position in global biopharma.
Biocon founder and chairperson Kiran Mazumdar-Shaw announced on 5 May 2026 a phased, five-year leadership transition plan naming her niece, Claire Mazumdar, as her successor. Claire Mazumdar, aged...
